B

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Environment Health & Safety Specialist

Environmental Health & SafetyConfirmed live in the last 24 hours
Full-timeKöniz, SwitzerlandNo salary listedIn-person

About the Job

Requirements

  • A Certified Occupational Safety and Health Specialist (ASGS) qualification with a Swiss Federal Diploma (eidgenössischer Fachausweis) or an equivalent Swiss-recognized qualification is required.
  • Several years of experience in occupational safety, health protection, and/or environmental management are required.
  • Strong knowledge of Swiss EHS regulations, EKAS Guideline No. 6508 (ASA Directive), and regulations under the Swiss Labor Code is required.
  • Experience in risk assessments, incident investigations, and implementing preventive measures is required.
  • Strong communication and stakeholder management skills, including the ability to influence and train employees at all levels, are required.
  • A structured, proactive, and solution-oriented working style is required.
  • Fluency in written and spoken German and English is required.

Responsibilities

  • Act as the EHS expert for occupational safety, health protection, and environmental compliance at the site.
  • Ensure compliance with applicable Swiss EHS legislation and regulatory requirements.
  • Conduct risk assessments, hazard analyses, and workplace inspections to identify and mitigate EHS risks.
  • Investigate EHS incidents, including accidents and near misses, and implement corrective and preventive actions.
  • Develop, coordinate, and maintain an effective emergency response organization.
  • Deliver EHS training and promote a strong safety culture across all levels of the organization.
  • Coordinate local and corporate EHS reporting and support hazardous waste management activities.

About the Company

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Bavarian Nordic develops, manufactures, and sells vaccines and cancer immunotherapies. Its vaccines and immunotherapies aim to train the body's immune system to recognize and attack cancer cells or infectious agents. The company operates as a fully integrated biotechnology business, handling development, production, and commercialization, and it collaborates with partners and licensing agreements to bring its products to market. A key differentiator is its track record, including European marketing authorization for an Ebola vaccine and a licensing deal for a COVID-19 vaccine, plus ongoing partnerships. The company's goal is to improve global health by reducing the risk of infectious diseases and by improving cancer treatment outcomes.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
1994

Recently Posted Jobs

Explore more opportunities at Bavarian Nordic

See more jobs